https://www.selleckchem.com/pr....oducts/BIRB-796-(Dor
re patients with longer follow-up to draw a more solid conclusion.Ischemic necrosis has been most dreaded complication of flap reconstruction. Therefore, researchers have tried to improvise modalities to prevent or treat it since the onset of flap surgery. So far these researches have failed to identify a pharmacological therapy equally effective as surgical delay in augmenting skin flap viability. In the path of search for this substance, dipyridamole attracted our attention as an antiaggregant agent. Put together with p
Like
Comment
Share
